| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scilex Holding Co | Director | Common Stock | 25,000 | $23,740 | $0.9496 | 17 Oct 2024 | Direct |
| CASI Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 388,387 | 25 May 2022 | Direct | ||
| Sorrento Therapeutics, Inc. | Director | Stock option (right to buy) | 250,000 | 30 Aug 2021 | Direct | ||
| Scilex Holding Co | Director | Nonstatutory Stock Option (right to buy) | 20,000 | 08 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SCLX | Scilex Holding Co | 08 Oct 2025 | 1 | $0 | 4 | Director | 09 Oct 2025, 08:47 |
| DNQAF | Denali Capital Acquisition Corp. | 22 Sep 2025 | 0 | $0 | 3 | Director | 23 Sep 2025, 19:52 |
| SCLX | Scilex Holding Co | 16 Dec 2024 | 1 | $0 | 4 | Director | 17 Dec 2024, 17:13 |
| SCLX | Scilex Holding Co | 17 Oct 2024 | 1 | +$18,992 | 4 | Director | 18 Oct 2024, 09:14 |
| SCLX | Scilex Holding Co | 20 Jun 2024 | 2 | +$7,050 | 4 | Director | 20 Jun 2024, 18:07 |
| SCLX | Scilex Holding Co | 04 Oct 2023 | 1 | $0 | 4 | Director | 05 Oct 2023, 21:26 |
| SCLX | Scilex Holding Co | 22 Sep 2023 | 0 | $0 | 3 | Director | 25 Sep 2023, 18:56 |
| /report/000110465922065267-wu-yue-alexander-2022-05-25 | CASI Pharmaceuticals, Inc. | 25 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 16:13 |
| /report/000120919121053986-wu-yue-alexander-2021-08-30 | Sorrento Therapeutics, Inc. | 30 Aug 2021 | 1 | $0 | 4 | Director | 30 Aug 2021, 20:16 |
| /report/000110465921081995-wu-yue-alexander-2021-06-15 | CASI Pharmaceuticals, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 16:02 |